Search
-
New#NewAlly | "AseBio is a bridge that allows us to connect with important sector leaders to ...
Meet Binit Tech, our new ally. We talked to Leandro Harillo, Technology Director.
-
New#NewMemberAseBio | 'AseBio is an excellent association that brings together the most impor...
Meet Zeta GmbH, our new member. We talked to Andreas Marchler, CEO of the company and with Christine Kolland, Business Development in Spain.
-
New#NewMemberAseBio | "AseBio is the collective voice of the biotechnology sector"
Meet Bexen Medical, our new member. We talked to Manuel Sánchez-Lagarejo, CEO of the company.
-
New#NewMemberAseBio | "AseBio is the major community of Spanish biotechnology that provides a...
Meet r Multipartner Virtual Data Room, our new member. We talked to María del Mar García, Area Manager Spain & LatAm at the company
-
New#BIOSPAIN2023Interview | "Biological therapies have become one of the main exponents of Pr...
Precision medicine has brought about a real revolution in the treatment of some diseases such as cancer. We analyze the latest advances from Promega, Silver Sponsor of BIOSPAIN 2023.
-
NewORYZON Announces Voting Results from its 2023 Annual General Meeting of Shareholders
All resolutions were approved and 35% of the issued shares represented.
-
NewWeLab Barcelona and Fundación MEDINA will collaborate to expand the offer of R&D services ...
This collaboration allows combining experience and resources for the discovery and development of new therapies.
-
NewAseBio and EuropaBio address the challenges of the Pharmaceutical Strategy and NGTs in Eur...
During the Presidency of the Council of the European Union, Spain will lead the dialogue on these critical policies for European patients, food safety, and the green transition.
-
NewGENESIS Biomed opens a new office in Valencia
This new location of GENESIS Biomed in the BioHub joins the existing locations in Barcelona and Madrid.
-
NewTagworks Pharmaceuticals Announces $64 Million in Series A Financing to Advance Click-to-R...
Financing round led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates, and Lightstone Ventures.
-
New#NewMemberAseBio| "AseBio will keep us informed and updated on status of these markets and...
Meet KINSY our new member. We talked to Alicia Hernández, Projects and Business Development Coordinator of the company.
-
NewPositive preclinical data of ORY-4001 for the treatment of Charcot-Marie-Tooth (CMT) disea...
Comprehensively reversed disease progression symptoms in a CMT mice model.
-
New‘JAMA Neurology’ publishes the results from Phase 1b/2a clinical trial of the neuroprotect...
The results from APRIL study, previously presented at the International Stroke Conference 2023, indicate that ApTOLL showed good safety in 151 acute ischemic stroke patients.
-
NewBiotech companies’ R&D investment grows by 16% in 2022 to reach €1,038 million
In 2021, the impact on GDP of biotech companies amounted to €11,183 million, or 1% of GDP
-
New#BIOSPAIN2023Interview | "The main risk factor for skin cancer is exposure to ultraviolet ...
On European Skin Cancer Prevention Day, we talk to Almirall, Platinum Sponsor of BIOSPAIN2023, about the importance of prevention and the main risk factors
-
NewZIP Solutions and YIMA Announce Strategic Co-Marketing Agreement for Gene Therapy
ZIP Solutions (Barcelona), a 100% affiliate of Biat Group (ticker BST), and YIMA, a Cyagen-owned AI-enabled biotech company, are please to announce a strategic co-marketing agreement for gene therapy.
-
NewReport | Biotechnology, driving change to tackle future food challenges
For World Environment Week, AseBio is analysing the role of biotechnology in tackling the challenges of the agrifood system, one of the main goals of BIOSPAIN 2023
-
NewBIOLAN succesfully advances in the development of the european project Aquavitae
BIOLAN is currently part of the AQUAVITAE project, funded by the European Commission and which main objective is to perform high quality research in the aquaculture field
-
NewProductLife Group acquires Cilatus and expands its expertise in complex product developmen...
Following the acquisitions of DS InPharmatics (DSI) in 2021 and Zwiers Regulatory Consultancy in 2022, ProductLife Group (PLG), a global provider of regulatory and compliance services to the life
-
New#NewMember | “AseBio connects innovative start-ups with industry and investors”
Meet Telum Therapeutics, our new member. We talked to Roberto Díez-Martínez, CEO y co- founder of the company.
-